# Metabolic Reprogramming by Andrographolide: Enhanced Pentose Phosphate Pathway and Antioxidant Capacity in Cortical Astrocytes

**Authors:** Pedro Cisternas, Paulina Ormazabal, Camila Gherardelli, Marianela Bastías-Pérez, Jose Brito-Valenzuela, Nibaldo C. Inestrosa

PMC · DOI: 10.3390/ph19010133 · 2026-01-12

## TL;DR

This study shows that andrographolide boosts antioxidant capacity and alters glucose metabolism in brain astrocytes, potentially offering neuroprotection.

## Contribution

The study reveals andrographolide's novel effect on astrocytic metabolic reprogramming via the pentose phosphate pathway and Wnt signaling.

## Key findings

- Andrographolide increases glucose uptake and antioxidant capacity in astrocytes.
- It enhances glucose-6-phosphate dehydrogenase activity and NADPH availability.
- The compound promotes redox maintenance over energy production in astrocytes.

## Abstract

Background/Objectives: Astrocytes are key regulators of brain energy homeostasis, integrating glucose metabolism with antioxidant support for neuronal function. Dysregulation of these processes contributes to neurodegenerative diseases, including Alzheimer’s disease. Andrographolide, a bioactive diterpenoid from Andrographis paniculata, has been reported to exert neuroprotective effects through the modulation of Wnt/β–catenin signaling and neuronal metabolism; however, its actions on astrocytic metabolic pathways remain insufficiently characterized. Methods: Here, we investigated the effects of andrographolide on metabolic and redox parameters in primary mouse cortical astrocytes. Results: Andrographolide increased glucose uptake and antioxidant capacity without affecting AMPK activation or the activity of core glycolytic enzymes. Instead, it selectively enhanced glucose-6-phosphate dehydrogenase activity, promoting glucose flux through the pentose phosphate pathway in a partially Wnt-dependent manner. This metabolic reprogramming was associated with increased NADPH availability and glutathione levels, together with a reduced ATP/ADP ratio, consistent with a shift toward redox maintenance rather than maximal energy production. Conclusions: Collectively, these findings highlight astrocytic metabolic plasticity as a relevant and underexplored target of andrographolide and support the concept that natural compounds can enhance brain resilience by modulating glial redox metabolism.

## Linked entities

- **Chemicals:** andrographolide (PubChem CID 5318517)
- **Diseases:** Alzheimer’s disease (MONDO:0004975)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** neurodegenerative diseases (MESH:D019636), Alzheimer's disease (MESH:D000544)
- **Chemicals:** glutathione (MESH:D005978), ADP (MESH:D000244), Andrographolide (MESH:C030419), diterpenoid (MESH:D004224), glucose (MESH:D005947), NADPH (MESH:D009249), Pentose Phosphate (MESH:D010428), ATP (MESH:D000255)
- **Species:** Andrographis paniculata (species) [taxon 175694], Mus musculus (house mouse, species) [taxon 10090]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12845274/full.md

---
Source: https://tomesphere.com/paper/PMC12845274